Samo prijavljeni korisnici mogu pregledati cijeli sadržaj.
ZAGREB, Dec 22
(Hina) - The Genera d.d. company said on the Zagreb
Stock Exchange on Thursday that the European commissioner for research
has signed a contract donating EUR 6 million for the second stage of
clinical trials of Osteogrow, a new drug for treating acute bone
fractures and defects.